You are using an older browser version. Please use a supported version for the best MSN experience.

INSMED INCORPORATED

NASDAQ: INSM
42.00
-0.08
-0.19%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Biotechnology & Medical Research
Highlights
Analyst Recommendation: Strong Buy
    • Revenue

    • 136.47M

    • Net Income

    • -254.34M

    • Market Cap.

    • 4.29B

    • Enterprise Value

    • 4.06B

    • Net Profit Margin %

    • -186.37

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.37

    • Forward P/E

    • -15.97

    • Price/Sales

    • 0.00

    • Price/Book Value

    • 14.42

    • Price/Cash flow

    • -

      • EBITDA

      • -224.70M

      • Return on Capital %

      • -30.54

      • Return on Equity %

      • -74.08

      • Return on Assets %

      • -30.54

      • Book Value/Share

      • 3.51

      • Shares Outstanding

      • 101.87M

      • Last Split Factor (Date)

      • 1:10 (3/3/2011)

      • Last Dividend (Ex-Date)

      • 0.00 (-)

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      1/22/2021
      Strong Buy
        • 1 Year Price Target

        • 53.50

        • Analysts

        • 9

        • EPS Estimate

        • -2.61

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • 12.24

        • 13.25

        • Net Income

          YTD/YTD (Last Year)

        • 21.57

        • 6.58

        • Net Income

          Q/Q (Last Year)

        • -4.91

        • -23.33

        • Sales (Revenue)

          5-Year Annual Average

        • -

        • -

        • Net Income

          5-Year Annual Average

        • -

        • -

        • Dividends

          5-Year Annual Average

        • -

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • 82.26

        • 61.61

        • Pre-Tax Margin

        • -185.80

        • -20.39

        • Net Profit Margin

        • -186.37

        • -15.56

        • Average Gross Margin

          5-Year Annual Average

        • -

        • 64.26

        • Average Pre-Tax Margin

          5-Year Annual Average

        • -729.24

        • -0.70

        • Average Net Profit Margin

          5-Year Annual Average

        • -728.44

        • -4.84

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • -

        • -

        • P/E Ratio 5-Year High

        • -

        • -

        • P/E Ratio 5-Year Low

        • -

        • -

        • Price/Sales Ratio

        • 31.41

        • 11.00

        • Price/Book Value

        • 14.42

        • 7.45

        • Price/Cash Flow Ratio

        • -

        • 27.89

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Biotechnology & Medical Research
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 1.03

        • 0.45

        • Current Ratio

        • 7.95

        • 3.42

        • Quick Ratio

        • 6.18

        • 2.99

        • Leverage Ratio

        • 2.35

        • 2.00

        • Book Value/Share

        • 3.51

        • 1.53

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 0.00

          • Key Metrics

          • Company

            • Payout Ratio

            • -

            • Dividend Date

            • -

            • Ex-Dividend Date

            • -

            • Last Split Factor

              new per old

            • 1:10

            • Last Split Date

            • 3/3/2011

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • -74.08

              (-84.62)

            • -15.67

              (-3.72)

            • Return on Assets %

              (5-Year Average)

            • -30.54

              (-49.62)

            • -7.26

              (-1.67)

            • Return on Capital %

              (5-Year Average)

            • -34.14

              (-55.49)

            • -9.27

              (-2.01)

            • Income/Employee

            • -629.55k

            • -74.17k

            • Inventory Turnover

            • 1.37

            • 2.87

            • Asset Turnover

            • 0.20

            • 0.37

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon